We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Resets Clinical Trial Application Requirements
Sponsors seeking to import drugs into Canada for trials must provide Health Canada with a “No Objection Letter” to facilitate shipment and demonstrate regulatory compliance, according to a November draft guidance on clinical trial applications (CTA).